Metric Finance
LearnFAQ
LearnFAQ

Learn / ANL

NASDAQ: ANL

Adlai Nortye Group Ltd. (ANL) stock, explained like you're 5

Adlai Nortye Group Ltd. trades on the Nasdaq under the ticker ANL. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1 billion dollars.

Ticker
ANL
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1 billion dollars

Is Adlai Nortye Group Ltd. a small, medium or large cap company?

No. Adlai Nortye Group Ltd. is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Adlai Nortye Group Ltd. makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ANL stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Adlai Nortye Group Ltd. (ANL) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Lilly and Merck will supply a cancer drug at no cost for a trial combining it with Adlai Nortye’s experimental treatment. (Stock Titan)
  • Adlai Nortye Group Ltd. (ANL) stock price, news, quote and history (Yahoo Finance Australia)
  • Adlai Nortye Group: Only For The Risk Tolerant After Massive Rally (NASDAQ:ANL) (Seeking Alpha)
  • Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year? (Yahoo Finance)

Follow ANL in your daily brief

Each trading day at 5 PM ET we post what happened to Adlai Nortye Group Ltd. and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ANL

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Adlai Nortye Group Ltd. stock

What does Adlai Nortye Group Ltd. do?

Adlai Nortye Group Ltd. trades on the Nasdaq under the ticker ANL. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1 billion dollars.

What is the ticker symbol for Adlai Nortye Group Ltd.?

Adlai Nortye Group Ltd. trades under the ticker ANL on the Nasdaq.

What is Adlai Nortye Group Ltd.'s market cap?

Adlai Nortye Group Ltd. is a small cap stock with a market cap of about 1 billion dollars.

How does Adlai Nortye Group Ltd. make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ANL stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ANL stock every day?

Add ANL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ANL daily

A free brief on Adlai Nortye Group Ltd. and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare ANL: ANL vs NVS, ANL vs AZN, ANL vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed